首页> 外国专利> METHOD FOR PREDICTING RECURRENCE OF PULMONARY TUBERCULOSIS

METHOD FOR PREDICTING RECURRENCE OF PULMONARY TUBERCULOSIS

机译:预测肺结核复发的方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, namely to laboratory studies in phthisiology; it can be used to predict the recurrence of pulmonary tuberculosis by examining blood serum. In patients with pulmonary tuberculosis caused by drug-resistant strains of M.tuberculosis, concentrations of interferon-γ, interleukin-10, autoantibodies to type I collagen and autoantibodies to type III collagen are determined in the midst of the disease by the ELISA method, and the high, medium, low risk of the recurrence or the complete absence of this risk is determined, according to the proposed algorithm. Step A: the concentration of interferon-γ is determined: at its value of 5.59 pg/ml and above, 0 points are assigned; at its value of 4.58-5.58 pg/ml, 1 point is assigned; at its value of 3.58-4.57 pg/ml and above, 2 points are assigned; at its value of 3.57 pg/ml and below, 3 points are assigned. Step B: a value is added to the obtained point value depending on a certain concentration of interleukin-10: at its value of 5.0 pg/ml and above, 0 points are added; at its value of 3.26-4.9 pg/ml, 1 point is added; at its value of 2.25 pg/ml and below, 2 points are added; at its value of 2.25-3.25 pg/ml, 3 points are added. Step C: a value is added to the obtained point value depending on a certain concentration of autoantibodies to collagen I: at its value of 7.1 mcg/ml and below, 0 points are added; at its value of 7.2-12.41 mcg/ml, 1 point is added; at its value of 13.43 mcg/ml and above, 2 points are added; at its value of 12.42-13.42 mcg/ml, 3 points are added. Step D: a value is added to the obtained point value depending on a certain concentration of autoantibodies to collagen III: at its value of 20.01 mcg/ml and above, 0 points are added; at its value of 12.18-20.0 mcg/ml, 1 point is added; at its value of 11.16 mcg/ml and below, 2 points are added; at its value of 11.17-12.17 mcg/ml, 3 points are added. Step E: Prediction of relapse risk: with a total score of 10-12, a high risk of recurrence is predicted; with a score of 7-9, the average risk of recurrence is predicted; with a total score of 4-6, a low risk of recurrence is predicted; with a score of 0-3, no risk of recurrence is predicted. ;EFFECT: method makes it possible to predict the recurrence of pulmonary tuberculosis caused by drug-resistant strains of M.tuberculosis by taking into account peculiarities of collagen metabolism disorders in these patients, which makes it possible to timely correct pathogenetic therapy aimed at normalizing collagen metabolism, reducing the massiveness and prevalence of residual changes in lung tissue, thereby increasing the efficiency of treatment of tuberculosis patients.;1 cl, 2 tbl, 5 ex
机译:田地:医学。物质:发明涉及医学,即抗肿瘤的实验室研究;它可用于通过检查血清来预测肺结核的复发。在抗毒性抗药性抗毒性菌株的肺结核患者中,通过ELISA方法在疾病中,在疾病中,在疾病中,通过ELISA方法确定干扰素-γ,白细胞介素-10,Inti胶原蛋白的自身抗体的浓度,根据所提出的算法,确定重复性的高,培养基,较小的风险或完全没有这种风险的风险。步骤答:确定干扰素-γ的浓度:在其值为5.59pg / ml及以上,分配0个点;在其值为4.58-5.58 pg / ml,分配1点;其值为3.58-4.57 pg / ml及以上,分配了2分;其值为3.57 pg / ml,低于3分,分配3个点。步骤B:根据白细胞介素-10的一定浓度向获得的点值加入值:在其值为5.0pg / ml及更高时,添加0个点;在其值为3.26-4.9 pg / ml,增加1点;其值为2.25 pg / ml,低于22分;在其值为2.25-3.25 pg / ml,加入3分。步骤C:将值加入到所获得的点值,取决于对胶原蛋白I的一定浓度I:在其值为7.1mcg / ml和以下值,增加0分;其值为7.2-12.41 mcg / ml,添加1点;其值为13.43 mcg / ml及以上,增加了2分;其值为12.42-13.42 mcg / ml,添加3个点。步骤D:根据对胶原III的一定浓度的自身抗体浓度加入所获得的点值的值:在其值为20.01mcg / ml及以上,添加0分;其值为12.18-20.0 mcg / ml,添加1点;在其值为11.16 mcg / ml及以下,增加了2分;其值为11.17-12.17 mcg / ml,添加了3个点。步骤e:复发风险预测:总得分为10-12,预测了高的复发风险;得分为7-9,预测了再次发生的平均风险;总得分为4-6,预测了较低的复发风险;得分为0-3,没有预测再次发生的风险。 ;效果:方法可以通过考虑这些患者的胶原蛋白代谢障碍的特性,预测由抗毒性抗药性抗药性菌株引起的肺结核的复发。可以及时正确正确地治疗胶原术治疗患者代谢,降低肺组织残留变化的浓度和患病率,从而提高结核病患者的治疗效率。; 1 cl,2 tbl,5前

著录项

  • 公开/公告号RU2762671C1

    专利类型

  • 公开/公告日2021-12-21

    原文格式PDF

  • 申请/专利权人

    申请/专利号RU2020140449

  • 发明设计人 TARASOVA LIUDMILA GENNADEVNA (RU);

    申请日2020-12-09

  • 分类号G01N33/68;G01N33/564;G01N33/573;

  • 国家 RU

  • 入库时间 2022-08-24 22:56:13

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号